Larner College of Medicine

The Hematology/Oncology conferences listed on this page are only open to Larner, UVM, and UVM Health students and employees.
 

Upcoming Hematology/Oncology Grand Rounds

Recent Grand Rounds Presentations

Academic Year 2026 - 2027

Body
SpeakerAffiliationPresentation 
Dermot Murphy, MD, MB BSThird Year Physician Fellow in Hematology and Medical Oncology, UVM HealthDelay in Diagnosis: Morbidity and Morality Conference
Elsy Rivera, MDThird Year Physician Fellow in Hematology and Medical Oncology, UVM HealthBeyond the Pain Crisis: From Vaso-Occlusion to Chronic Pain in Sickle Cell Disease
 Jaina Clough, MDHospice and Palliative Medicine, UVM Health - UVM Medical Center & UVM Home Health & HospiceACT 39: Medical Aid in Dying in Vermont (Clinical Review)
 Duaa Kanan, MDSecond Year Physician Fellow in Hematology and Medical Oncology, UVM HealthCurrent and Novel Applications of Therapeutic Plasma Exchange in Hematology and Oncology
Megan Tesch, MD, MPHMedical Breast Oncologist, Dana Farber Cancer Institute and Instructor in Medicine, Harvard Medical SchoolEarly Onset Breast Cancer: Interplay Between Tumor Biology and Host Factors
Sarah Gillett, MD, PhDHematology and Oncology, UVM Health/Larner College of MedicineBreaking the RAS Barrier: The KRAS Revolution in Pancreatic Cancer: From "undruggable" oncogene to first approved targeted therapy in PDAC
Meredith Ryan, MDSecond Year Fellow in Hematology and Medical Oncology, UVM HealthLearning Oncology in 2026

 

Academic Year 2025 - 2026

Body

 

SpeakerAffiliationGrand Rounds Presentation
Dr. Sienna SearlesFirst Year Physician Fellow in Hematology and Medical Oncology, UVM HealthThe Effects of Plastic Exposure on Human Health: An Introduction and Review
Dr. Elsy RiveraSecond Year Physician Fellow in Hematology and Medical Oncology, UVM HealthFatal Rhino-Orbital-Cerebral Mucormycosis in a Post-Transplant AML Patient
Alexander Boucher, MDPediatric Hematology/Oncology; Medicine-Hematology, Oncology, and Transplantation, University of MinnesotaSickle Call Disease Care: Harnessing the Headwinds
Meredith Ryan, MDSecond Year Physician Fellow in Hematology and Medical Oncology, UVM HealthGermline Testing in Myeloid Malignancies
Shruti Khurana, MDMedicine - Gastroenterology/UVM Health Chron's and Colitis CenterCellular Therapies for Inflammatory Bowel Disease: An IBD Specialist's Perspective
Elsy Rivera, MDSecond Year Physician Fellow in Hematology and Medical Oncology, UVM HealthDe-Mystifying Systems Hematology
Dermot Murphy, MD, MB BSSecond Year Physician Fellow in Hematology and Medical Oncology, UVM HealthClonal Hematopoiesis: Causes and Consequences
Jinah Kim, MDThird Year Physician Fellow in Hematology and Medical Oncology, UVM HealthGLP-1 Receptor Agonists: An Oncology Perspective
Jacqueline Poston, MDPathology and Laboratory Medicine; Hematology and Oncology, Larner College of Medicine and UVM HealthTransfusion Challenges and Opportunities for Hematologic Malignancies in 2026
Chris Holmes, MD, PhDDivision Chief, Hematology and Oncology, UVM LCOM/UVM HealthIntegrating Biology, Clinical Trials, and Implementation Science to Prevent Thrombotic Complications in Patients with Cancer
Ike Chidobem, MDThird Year Physician Fellow in Hematology and Medical Oncology, UVM HealthMorbidity and Mortality Conference
Duaa Kanan, MDFirst Year Physician Fellow in Hematology and Medical Oncology, UVM HealthA Focus on Cancer Prevention and Molecular Oncology
Deena Snoke, PhDPost-Doctoral Research Associate, Toth Laboratory, Department of Medicine - Pulmonary and Critical CareTemporal variation in body composition during the lung cancer continuum
Jinah Kim, MDThird Year Fellow in Hematology and Medical Oncology, UVM HealthFellows Conference/Morbidity & Mortality Conference: Fatal Outcome After CAR-T Complicated by CRS/ICANS
Jay Raval, MDPathology and Laboratory Medicine, Larner College of Medicine and UVM HealthTherapeutic Plasma Exchange: Updates in Evidence for Practice Patterns in Procedure Performance
Dermot Murphy, MD, MB BSSecond Year Fellow in Hematology and Medical Oncology, UVM Health
Fellows Conference: "Recent Developments in Mantle Cell Lymphoma"
Michael Kroll, MDEmeritus, MD Anderson Cancer Center, University of TexasHematologic Complications of Checkpoint Inhibitors

Marlise Luskin, MD

 

Dana Farber Cancer Institute

Ph+ ALL: Progress and Prospects

 

Academic Year 2024-2025

Body

For prior years Grand Rounds schedule please contact Whitney Feininger

SpeakerAffiliationPresentation 

David Iberri, MD

 

Stanford University

How I avoid overtreating myeloma: Musings of a west coast myeloma doctor

 

Jonathan Boyson, PhDUniversity of Vermont

Emerging roles of gamma delta T cells in cancer

 

Elizabeth BuchbinderDana Farber Cancer Institute

What's new in melanoma and what we do when standard therapies fail

 

Marco Ruella, MDPenn Medicine

Catch me if you can: Resistance to CAR-T immunotherapy

 

 

Adam Cuker, MD

 

Penn Medicine

Diagnosis and Management of Heparin-Induced Thrombocytopenia: An updated based on the ASH Guidelines

 

Douglas Sborov

 

Huntsman Cancer InstituteThe New Frontier of Multiple Myeloma

Jennifer Kelly, MD 

 

University of VermontBone health management in patients undergoing treatment for malignancy

 

Ryan Thomas, MD

 

University of VermontMorbidity and Mortality Conference

 

Maija Reblin, PhD

 

University of VermontCaregiver Needs in Vermont

 

Elsy Rivera, MD

 

University of Vermont
 Anticoagulant & Antithrombotic Herbs

 

Rahul Vedula, MD

 

Dana Farber Cancer Institute"CRISPR-based rapid diagnostics for fusion driven leukemias"
Jinah Kim, MDUniversity of VermontThe immunotherapy in early triple-negative breast cancer

 

Haze Xu, MD

 

University of VermontRethinking the Obesity Paradox: Immune Checkpoint Inhibitor and The New Frontier

Amanda Kallen, MD

 

University of Vermont"Parenthood on Ice: Safeguarding Reproductive Potential During Gonadotoxic Therapy"

Dr. Dermot Murphy

 Dr. Ann Kim

 

University of Vermont (Murphy) 

Dana Farber (Kim)

Morbidity and Mortality Conference
Shruti Khurana, MD Immune Checkpoint Inhibitor Colitis
Dr. Ike Chidobem, 2nd Year Fellow in Hematology and Medical Oncology, UVM Health Network  Bruton's Tyrosine Kinase (BTK) Inhibitors in Chronic Lymphocytic Leukemia (CLL) 
Dr. Ryan Thomas, 3rd Year Fellow in Hematology and Medical Oncology, UVM Health Network Quality Improvement Projects
Dr. Jacqueline Poston, UVM Department of Pathology and Laboratory Medicine Revolutionizing Care: The Management of Acquired Hemophilia A in 2025
Dr. Jinah Kim, 2nd Year Fellow in Hematology and Medical Oncology, UVM Health Network Morbidity and Mortality Conference: A Fatal Opportunistic Infection: Mucormycosis 
Dr. Radhika Gangaraju, University of Alabama - Birmingham Thrombosis in Hematologic Malignancies: Risk Factors and Emerging Biomarkers
Dr. Ike Chidobem, 2nd Year Fellow in Hematology and Medical Oncology, UVM Health Network Adjuvant CDK 4/6 Inhibitors in HR+/HER2-Breast Cancer